Support device

The support device for drug packaging apparatuses assists in drug distribution by adding a frame with indicators, allowing for accurate cell identification and distribution without altering the apparatus, thus maintaining its original functionality.

JP2026181787APending Publication Date: 2026-11-19TAKAZONO CORP
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2025077468
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-07
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing drug packaging apparatuses require modifications to assist in drug distribution operations, which is undesirable due to the potential for significant changes and disruptions.

Method used

A support device is added to the drug packaging apparatus, featuring a frame with indicators corresponding to each cell in the tray, providing visual assistance for accurate drug distribution without altering the apparatus's core structure.

Benefits of technology

Enables efficient and accurate drug distribution without modifying the drug packaging apparatus, using indicators to guide users on which cells to fill, ensuring minimal disruption and ease of use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026181787000001_ABST
    Figure 2026181787000001_ABST
Patent Text Reader

Abstract

This system enables support for distribution operations without requiring any special modifications to the drug packaging equipment. [Solution] The support device 1 is retrofitted to a tray 8, which has multiple cells 85 into which pharmaceuticals are introduced from an input port 85a, and is included in a pharmaceutical packaging device 100 for packaging pharmaceuticals. The support device 1 comprises a frame 2 placed on the tray 8 and multiple indicators 3 positioned on the frame 2 at locations corresponding to each of the multiple cells 85.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The technology disclosed herein relates to an assistance device. BACKGROUND ART

[0002] Conventionally, a drug packaging apparatus has been disclosed that includes a storage section for storing drugs in subdivided states, and packages the drugs in the storage section with packaging paper. For example, Patent Document 1 discloses a known drug packaging apparatus provided with a storage section having a plurality of cells into which drugs are charged from an inlet. In such a drug packaging apparatus, a user manually charges drugs from the inlet into the cells, so that a required amount of drugs is distributed into the plurality of cells. PRIOR ART DOCUMENTS PATENT DOCUMENTS

[0003] PATENT DOCUMENT 1 International Publication No. 2008 / 035701 SUMMARY OF THE INVENTION PROBLEMS TO BE SOLVED BY THE INVENTION

[0004] In such a drug packaging apparatus, it is desirable that some kind of assistance be provided so that the drug distribution operation is performed appropriately. However, in order to incorporate a configuration for assisting the distribution operation into the drug packaging apparatus, design changes or the like of the drug packaging apparatus are required. Further, when adding a configuration for assisting the distribution operation to an existing drug packaging apparatus, it is preferable that modifications and other changes be minimized as much as possible.

[0005] The technology disclosed herein has been made in view of the above points, and an object thereof is to realize assistance for distribution operations without making special changes or the like to a drug packaging apparatus. MEANS FOR SOLVING THE PROBLEMS

[0006] The support device disclosed herein is an add-on device for a drug packaging device that packages drugs, which is attached to a tray having a plurality of cells into which drugs are introduced from an input opening, and comprises a frame placed on the tray and a plurality of indicators arranged on the frame at positions corresponding to each of the plurality of cells. [Effects of the Invention]

[0007] According to the aforementioned support device, assistance for distribution work can be achieved without making any special modifications to the drug packaging device. [Brief explanation of the drawing]

[0008] [Figure 1] Figure 1 is a perspective view of a drug packaging device. [Figure 2] Figure 2 is a schematic diagram showing the configuration of a drug packaging device. [Figure 3] Figure 3 is a perspective view of the drug packaging device with the table extended forward. [Figure 4] Figure 4 is an enlarged perspective view of the trays placed on the table. [Figure 5] Figure 5 is a cross-sectional view of the tray along the VV line in Figure 4. [Figure 6] Figure 6 is a perspective view of a drug packaging device with a support device installed. [Figure 7] Figure 7 is a perspective view of the support device. [Figure 8] Figure 8 is a perspective view of the support device, seen from a different angle than in Figure 7. [Figure 9] Figure 9 is a cross-sectional view of the support equipment on the IX-IX line shown in Figure 7. [Figure 10] Figure 10 is a cross-sectional view of the support device and tray in the same cross-section as Figure 9. [Figure 11] Figure 11 is an enlarged view of the cross-section of the support device and tray shown in Figure 10. [Figure 12] Figure 12 shows the hardware configuration of the control device. [Figure 13] Figure 13 is a perspective view of a drug packaging device according to Modification 1. [Figure 14] Figure 14 is a perspective view of the support device according to Modification 1. [Figure 15] Figure 15 is a perspective view of the support device, viewed from an angle different from that of Figure 14. [Figure 16] Figure 16 is an enlarged cross-sectional view of the support device and the tray in a cross section parallel to the row direction. [Figure 17] Figure 17 is an enlarged cross-sectional view of the support device and the tray in a cross section parallel to the column direction. [Figure 18] Figure 18 is a perspective view of the drug packaging device according to Modification 2. [Figure 19] Figure 19 is a perspective view of the support device according to Modification 2. [Figure 20] Figure 20 is a perspective view of the support device, viewed from an angle different from that of Figure 19. [Figure 21] Figure 21 is an enlarged cross-sectional view of the support device and the tray. [Mode for Carrying Out the Invention]

[0009] Hereinafter, exemplary embodiments will be described in detail with reference to the drawings. Figure 1 is a perspective view of the drug packaging device 100. Figure 2 is a schematic diagram showing the configuration of the drug packaging device 100.

[0010] The drug packaging device 100 divides drugs into small portions and packages the divided drugs with a packaging material. The drug packaging device 100 includes a tray 8 having a plurality of cells 85 into which drugs are charged from a charging port 85a. Drugs are distributed to the plurality of cells 85 by so-called manual sprinkling. The tray 8 stores drugs in a divided manner in the plurality of cells 85. For example, the drug packaging device 100 includes a drug supplier 91 that supplies drugs, and a drug packaging unit 92 that packages the drugs supplied from the drug supplier 91. The tray 8 is included in the drug supplier 91. The drug supplier 91 supplies the drug to the drug packaging unit 92 for each cell 85 of the tray 8. The drug packaging unit 92 packages the drugs supplied from the drug supplier 91 with a packaging material.

[0011] For example, the medicine is a solid medicine. Specifically, the medicine is a tablet, a pill, a capsule, or a powder. A tablet, a pill, or a capsule is dispensed into the plurality of cells 85, and no powder is dispensed therein.

[0012] The medicine packaging apparatus 100 may further include a control device 93 that controls the medicine supplier 91 and the medicine packaging unit 92. The control device 93 executes a process of dividing and packaging the medicine by controlling the medicine supplier 91 and the medicine packaging unit 92.

[0013] The housing 90 of the medicine packaging apparatus 100 accommodates the medicine supplier 91 and the medicine packaging unit 92. The tray 8 is exposed to the outside of the housing 90. For example, the tray 8 is arranged on the upper surface of the housing 90. The housing 90 also accommodates the control device 93.

[0014] The medicine packaging apparatus 100 may further include an input device 95 and a display 96. The input device 95 is operated by a user to input various kinds of information to the control device 93. The input device 95 is, for example, a switch, a keyboard, a touch panel, a mouse, or a touch pad. The display 96 displays various kinds of information. For example, the display 96 displays information related to divided packaging. The display 96 may display the information input from the input device 95. The display 96 is, for example, a liquid crystal display or an organic EL display. The input device 95 and the display 96 are arranged on the upper surface of the housing 90.

[0015] The medicine packaging apparatus 100 may include a lid 98 that covers the tray 8 from above. The lid 98 is rotatably attached to the upper surface of the housing 90. The lid 98 rotates between a closed position where it lies over the tray 8 to cover the tray 8, and an open position where it stands up from the upper surface of the housing 90 to expose the tray 8. When the medicine packaging apparatus 100 is in use, the lid 98 is positioned at the open position to expose the tray 8. When the medicine packaging apparatus 100 is not in use, the lid 98 is positioned at the closed position to cover the tray 8.

[0016] The tray 8 is detachably attached to the drug packaging device 100. For example, the tray 8 is detachably attached to the housing 90. The tray 8 may also be detachably positioned on the top surface of the housing 90. For example, a table 97 is positioned on the top surface of the housing 90. The table 97 has a recess into which the tray 8 fits. The tray 8 is placed in the recess of the table 97.

[0017] Figure 3 is a perspective view of the drug packaging device 100 with the table 97 extended forward. In Figure 3, the lid 98 is in the closed position. The table 97 may be slidable in a predetermined sliding direction on the upper surface of the housing 90. The sliding direction may be approximately parallel to the horizontal direction. For example, if the side of the drug packaging device 100 facing the user is considered the front, the sliding direction is the front-to-back direction. For the sake of explanation, left and right are defined based on a view from front to back. The table 97 is movable in the sliding direction between the usage position and the attachment / detachment position. The usage position is the position when the tray 8 is used, that is, when the drug is packaged. The attachment / detachment position is the position when the tray 8 is attached to or detached from the table 97, and is in front of the usage position.

[0018] Figure 4 is an enlarged perspective view of tray 8 placed on table 97. In tray 8, multiple cells 85 are arranged two-dimensionally. For example, multiple cells 85 are arranged in a matrix. In this example, multiple cells 85 are arranged in a 6x8 matrix. Tray 8 is formed in a grid pattern to partition the multiple cells 85.

[0019] Figure 5 is a cross-sectional view of tray 8 along the VV line in Figure 4. The VV line corresponds to the positions of multiple cells 85 in the third row. Each cell 85 is composed of a through-hole that penetrates the tray 8. Tray 8 has a first surface 81 and a second surface 82 facing opposite directions from each other. The first surface 81 is the surface facing outwards from the housing 90. For example, the first surface 81 faces upward. The second surface 82 faces the top surface of the housing 90. For example, the second surface 82 faces downward. Cells 85 have openings on the first surface 81 and the second surface 82. The opening on the first surface 81 of a cell 85 is the drug inlet 85a. Drugs are loaded into multiple cells 85 from the inlet 85a. The opening on the second surface 82 of a cell 85 is the drug outlet 85b. The multiple inlet 85a are arranged in a matrix, similar to the multiple cells 85. The shape of the input opening 85a is, for example, a square with rounded corners.

[0020] The first surface 81 of the tray 8 may have a recess 83 that is more recessed than the rest of the first surface 81. That is, the first surface 81 includes the bottom surface of the recess 83 and an outer peripheral surface that is positioned around the outer periphery of the recess 83 and is higher than the bottom surface of the recess 83. The input opening 85a is located in the recess 83. A step 83a is formed at the boundary between the recess 83 and the rest of the first surface 81. That is, the outer periphery of the recess 83 is demarcated by the step 83a. For example, as shown in Figure 4, the step 83a is positioned to form the four sides of a rectangle surrounding the outer periphery of the recess 83.

[0021] As shown in Figure 4, the tray 8 has handles 86 that are grasped by the user. The tray 8 has two handles 86. The handles 86 are located on the outer circumference of the tray 8.

[0022] The drug dispenser 91 receives the drugs discharged from multiple cells 85 in the same manner as the multiple cells 85, and supplies the divided drugs individually to the drug packaging machine 92.

[0023] The drug dispenser 91 may be located below the tray 8 and have a first shutter 99 that opens and closes the cells 85. The first shutter 99 opens and closes multiple cells 85. For example, the first shutter 99 opens and closes the discharge port 85b of the cell 85. When the first shutter 99 is closed, the drug in the cell 85 is retained in the cell 85 by the first shutter 99. When the first shutter 99 opens, the drug in the cell 85 falls downward and is discharged from the cell 85.

[0024] Although not shown in the diagram, the configurations of the drug dispenser 91 and the drug packaging device 92 will be briefly explained.

[0025] The drug dispenser 91 may be located below the first shutter 99 and further include a container for receiving drugs discharged from multiple cells 85, a second shutter for opening and closing the container, and a guide for guiding the drugs discharged from the container to the drug packaging device 92.

[0026] The containment container may receive the drugs discharged from multiple cells 85 separately for each cell 85. For example, the containment container has multiple cells corresponding to multiple cells 85 in tray 8. The drugs discharged from each 85 are received into the corresponding cells of the containment container.

[0027] The second shutter is located below the multiple cells. The second shutter opens and closes the multiple cells. When the second shutter is closed, the drug inside the cell is retained by the second shutter. When the second shutter opens, the drug inside the cell falls downward and is discharged from the cell. The second shutter opens and closes the multiple cells individually. That is, the drug contained in the container is discharged from each cell.

[0028] The guide receives the drugs discharged from each of the multiple cells and directs the received drugs to the hopper of the drug packaging device 92, which will be described later.

[0029] The drug packaging device 92 may include a hopper, a conveyor for transporting the packaging material, and a sealer for sealing the packaging material.

[0030] The conveyor transports the packaging material, which is a long sheet, in a state where it has been folded in half in the width direction. The conveyor then unfolds the folded packaging material at a position corresponding to the hopper.

[0031] The hopper receives the medication guided by the guide. The hopper collects the medication from the guide and supplies it to the packaging material. The hopper supplies the medication between the two sheets of the folded packaging material.

[0032] The sealing device seals the packaging material after the drug has been supplied from the hopper. The sealing device seals the packaging material by heat, for example. The sealing device seals the folded packaging material into a bag shape. The sealing device seals the edges of the two sheets of packaging material together and also seals the two sheets in a striped pattern in the width direction, thereby dividing the space between the two sheets into a compartment for containing the drug.

[0033] In such a drug dispenser 91 and drug packaging device 92, the drugs contained in multiple cells 85 of the tray 8 are packaged sequentially in packaging material, cell by cell 85. In other words, the drugs contained in each cell 85 of the tray 8 are packaged as one package. For example, starting with the cell 85 in the first row of the first column, the drugs in each cell 85 in the first column are packaged in ascending order of row number. Once all the drugs in the cells 85 of the first column have been packaged, the drugs in each cell 85 of the second column are packaged in ascending order of row number. This process of packaging the drugs in each cell 85 continues until all the drugs in all the cells 85 containing drugs have been packaged.

[0034] Figure 6 is a perspective view of the drug packaging machine 100 with the support device 1 installed. The support device 1 is installed in the drug packaging machine 100. The support device 1 assists the user in manually dispensing the drug onto the tray 8. The support device 1 is placed on the tray 8.

[0035] Figure 7 is a perspective view of the support device 1. Figure 8 is a perspective view of the support device 1 from a different angle than in Figure 7. The support device 1 comprises a frame 2 placed on a tray 8 and a plurality of display units 3 provided on the frame 2 and positioned corresponding to each of the plurality of cells 85. By placing the support device 1 on the tray 8, the display units 3 are retrofitted to the positions corresponding to the plurality of cells 85. In other words, a display unit 3 corresponding to each cell 85 is installed on the drug packaging device 100. The display units 3 display information according to their purpose, allowing the user to identify the target cell 85 from among the plurality of cells 85.

[0036] The arrangement of multiple display units 3 corresponds to the arrangement of multiple cells 85. If the multiple cells 85 are arranged in a matrix, the multiple display units 3 are also arranged in a matrix, similar to the multiple cells 85. For example, the multiple display units 3 are arranged in a 6x8 matrix, similar to the multiple cells 85. The pitch of the multiple display units 3 in the column direction is approximately the same as the pitch of the multiple cells 85 in the column direction. The pitch of the multiple display units 3 in the row direction is approximately the same as the pitch of the multiple cells 85 in the row direction.

[0037] The display unit 3 may also display information to identify the corresponding cell 85. For example, the display unit 3 may display information indicating that the corresponding cell 85 is the cell 85 into which the drug should be administered.

[0038] The multiple indicators 3 may also be multiple light emitters. The indicators 3 are also referred to as light emitters 3. The multiple light emitters 3 may be configured so that the color of the light can be changed independently. That is, the multiple light emitters 3 can change color individually. Each light emitter 3 emits light in multiple different colors. For example, each light emitter 3 can change its emitted color to eight colors including white (red, yellow, blue, purple, cyan, orange, green, white). For example, each light emitter 3 includes an LED (Light Emitting Diode).

[0039] Multiple light emitters 3 emit light to identify the corresponding cell 85. For example, the light emitters 3 inform the user by emitting light that the corresponding cell 85 is the cell 85 into which the drug should be introduced. Furthermore, the light emitters 3 may indicate the type and / or number of drugs to be introduced into the corresponding cell 85 by the color of the emitted light.

[0040] For example, the light emitter 3 may indicate by the color of emission that the corresponding cell 85 is the cell 85 to which a specific drug should be introduced. For example, the light emitter 3 corresponding to the cell 85 to which the first drug should be introduced emits a first color, the light emitter 3 corresponding to the cell 85 to which the second drug should be introduced emits a second color, and the light emitter 3 corresponding to the cell 85 to which the third drug should be introduced emits a third color.

[0041] The light emitter 3 may indicate by the color of emission that the corresponding cell 85 is the target cell 85 into which a specific number of drugs should be administered. For example, the light emitter 3 corresponding to a cell 85 into which one drug should be administered emits a first color, the light emitter 3 corresponding to a cell 85 into which two drugs should be administered emits a second color, and the light emitter 3 corresponding to a cell 85 into which three drugs should be administered emits a third color.

[0042] Frame 2 has multiple through-holes 25 separated to communicate with each of the multiple cells 85. For example, frame 2 is formed in a grid pattern to partition the multiple through-holes 25. The arrangement of the multiple through-holes 25 corresponds to the arrangement of the multiple cells 85. If the multiple cells 85 are arranged in a matrix, the multiple through-holes 25 are also arranged in a matrix pattern, similar to the multiple cells 85. For example, the multiple through-holes 25 are arranged in a 6x8 matrix pattern, similar to the multiple cells 85. The pitch of the multiple through-holes 25 in the column direction is approximately the same as the pitch of the multiple cells 85 in the column direction. The pitch of the multiple through-holes 25 in the row direction is approximately the same as the pitch of the multiple cells 85 in the row direction. Frame 2 is formed as a whole in a plate shape.

[0043] As shown in Figure 7, frame 2 has a first surface 21 that faces outward when frame 2 is placed on tray 8. As shown in Figure 8, frame 2 has a second surface 22 that contacts tray 8 when frame 2 is placed on tray 8.

[0044] Frame 2 has a plurality of first digits 23 extending in a first direction and a plurality of second digits 24 extending in a second direction intersecting the first direction, and the plurality of first digits 23 and plurality of second digits 24 constitute a grid. The plurality of first digits 23 and plurality of second digits 24 intersect with each other and partition, i.e., divide, a plurality of through holes 25. Specifically, each through hole 25 is partitioned by two opposing first digits 23 and two opposing second digits 24. For example, the plurality of first digits 23 and plurality of second digits 24 are orthogonal to each other. When the plurality of through holes 25 are arranged in a matrix, the plurality of first digits 23 extend in the row direction and the plurality of second digits 24 extend in the column direction.

[0045] Multiple through holes 25 penetrate the frame 2. The axes of the multiple through holes 25 are approximately parallel to each other. The axes of the multiple through holes 25 may also be approximately parallel to the thickness direction of the frame 2.

[0046] The through hole 25 has a first opening 25a that opens to the first surface 21 and a second opening 25b that opens to the opposite side of the first surface 21. The second opening 25b is the opening of the through hole 25 on the side of the input port 85a.

[0047] The shape of the first opening 25a is, for example, a square with rounded corners. The shape of the second opening 25b is, for example, a square with rounded corners. The cross-sectional shape of the through hole 25 may be constant along the axial direction of the through hole 25. In that case, the cross-sectional shapes of the first opening 25a, the second opening 25b, and the through hole 25 are substantially the same.

[0048] Multiple indicators 3 are arranged in multiple first digits 23 and / or multiple second digits 24. For example, multiple indicators 3 are arranged in the portion of the multiple first digits 23 and / or multiple second digits 24 corresponding to the inner circumferential surface of multiple through holes 25. One indicator 3 is arranged on the inner circumferential surface of each through hole 25. The indicator 3 may be arranged on the inner circumferential surface of the through hole 25 at the end on the first opening 25a side in the axial direction of the through hole 25.

[0049] For example, multiple indicators 3 are arranged in multiple second digits 24, as shown in Figure 7. In all through-holes 25, it is common which indicator 3 corresponds to which second digit 24 (left or right). In the example in Figure 7, each through-hole 25 has an indicator 3 corresponding to the left second digit 24.

[0050] Figure 9 is a cross-sectional view of the support device 1 along the IX-IX line in Figure 7. The IX-IX line corresponds to the positions of the multiple through holes 25 in the third row. The girders on which the multiple indicators 3 are installed among the multiple first girders 23 and multiple second girders 24 have an internal space for housing the substrate 32 for the indicators 3. That is, the girders are formed in a hollow manner. In the example of Figure 9, the multiple second girders 24 on which the multiple indicators 3 are arranged have an internal space 24a for housing the substrate 32. The internal space 24a may open on the side opposite to the first surface 21 of the frame 2.

[0051] The display unit 3 includes a circuit board 32. The circuit board 32 has LEDs and a circuit that makes the LEDs light up. The circuit boards 32 of multiple display units 3 arranged in the same digit are integrally constructed. That is, the LEDs of multiple display units 3 arranged in the same digit are mounted on a common circuit board 32.

[0052] Frame 2 may have a frame body 20 and a cover 4, as shown in Figure 8. For example, the frame body 20 includes a plurality of first digits 23, a plurality of second digits 24, and a plurality of through holes 25. The cover 4 is attached to the frame body 20. The frame body 20 and the cover 4 partition a space 44 for housing wiring to the display unit 3, as shown in Figure 9. In other words, the wiring to the display unit 3 is housed in the space 44 partitioned by the frame body 20 and the cover 4.

[0053] The frame body 20 may further include a top plate 26 having a first surface 21. Multiple first digits 23 and multiple second digits 24 extend from the top plate 26 to the side opposite the first surface 21.

[0054] For example, cover 4 is attached to the side of the top plate 26 opposite to the first surface 21. Cover 4 may be formed in an annular shape so as to surround all the first digits 23 and second digits 24 from the side. For example, cover 4 is formed in a roughly rectangular frame shape.

[0055] The cover 4 may have a bottom wall 41 that extends substantially parallel to the first surface 21, and a side periphery wall 42 that is connected to the bottom wall 41 and surrounds the first girder 23 and the second girder 24 from the outer circumference.

[0056] For example, the bottom wall 41 includes an annular first bottom wall 41a that surrounds the first digit 23 and the second digit 24 from the outer circumference, and a second bottom wall 41b that extends along the second digit 24. Both ends of each second bottom wall 41b are connected to the first bottom wall 41a. The second bottom wall 41b closes off the internal space 24a of the corresponding second digit 24. The two outermost second digits 24 in the row direction are closed off by the first bottom wall 41a. That is, the internal space 24a is partitioned by the second digits 24 and the bottom wall 41. Multiple first digits 23 and multiple second digits 24 protrude downward from the bottom wall 41.

[0057] The side periphery wall 42 is formed in an annular shape so as to surround the outermost two first digits 23 in the column direction and the two second digits 24 in the row direction from the outer periphery.

[0058] The cover 4 may include ribs 43 that project from the bottom wall 41 toward the opposite side of the first surface 21, i.e., downward. For example, the ribs 43 are formed in an annular shape so as to surround the first digit 23 and the second digit 24 from the outer circumference. That is, the ribs 43 are formed in an annular shape so as to surround the outer circumference of the two outermost first digits 23 in the column direction among a plurality of first digits 23 and the two outermost second digits 24 in the row direction among a plurality of second digits 24.

[0059] The lower end surface of the rib 43 and the lower end surfaces of the first girder 23 and the second girder 24 are substantially flush. The lower end surfaces of the first girder 23, the second girder 24, and the rib 43 form a second surface 22. When the frame 2 is placed on the tray 8, the lower end surfaces of the first girder 23, the second girder 24, and the rib 43 come into contact with the tray 8, specifically the first surface 81.

[0060] Frame 2 may have extension plates 27 that extend to cover the handles 86 of the tray 8. For example, the top plate 26 includes two extension plates 27. The two extension plates 27 are positioned at both ends in the row direction of a plurality of cells 85 on the top plate 26. When frame 2 is placed on the tray 8, the two extension plates 27 cover the two handles 86 from above. The extension plates 27 make the handles 86 invisible from above. By covering the handles 86 with the extension plates 27, the user cannot access the handles 86. As a result, it is prevented that the user may accidentally remove the tray 8 from the drug packaging device 100 while the support device 1 is installed on the tray 8.

[0061] The frame 2 may have a storage section 28 for housing a tool for picking up the drug, as shown in Figure 7. The storage section 28 may be located on the frame body 20. For example, the storage section 28 is formed by a recess that is recessed from the first surface 21. For example, the tool for picking up the drug is tweezers 28a.

[0062] The support device 1 may have a cover 29. The cover 29 is rotatably mounted on the first surface 21 of the frame 2. The cover 29 rotates between a closed position, where it folds down against the first surface 21 to close the multiple through holes 25, and an open position, where it stands up from the first surface 21 to open the multiple through holes 25. When the support device 1 is in use, the cover 29 is positioned in the open position, exposing the multiple through holes 25. When the support device 1 is not in use, the cover 29 is positioned in the closed position, covering the multiple through holes 25.

[0063] Figure 10 is a cross-sectional view of the support device 1 and tray 8 in the same cross-section as in Figure 9. When the support device 1 is placed on the tray 8, each of the multiple through holes 25 communicates with a corresponding cell 85. In other words, one through hole 25 communicates with a corresponding cell 85.

[0064] Of the multiple through holes 25, the opening on the side of the input port 85a, i.e., the second opening 25b, is positioned so as to fit within the input port 85a of the cell 85. In other words, when viewed from above, the opening edge of the input port 85a is not visible inside the through hole 25. For example, the size of the second opening 25b is less than or equal to the size of the input port 85a. Preferably, the size of the second opening 25b is smaller than the size of the input port 85a.

[0065] Figure 11 is an enlarged cross-sectional view of the support device 1 and tray 8 shown in Figure 10. Figure 11 is an enlarged view of the area around the first row of through holes 25 and cells 85. The support device 1 may further include a positioning member for positioning the frame 2 in a direction parallel to the surface of the tray 8 on which the frame 2 is placed. The positioning member positions the frame 2 by contacting a corresponding part of the tray 8. For example, the surface of the tray 8 on which the frame 2 is placed is the first surface 81. More specifically, the surface of the tray 8 on which the frame 2 is placed is the bottom surface of the recess 83 on the first surface 81. For example, the positioning member is a rib 43. For example, the corresponding part of the tray 8 is the step 83a on the first surface 81. When the support device 1 is placed on the tray 8, the second surface 22 of the frame 2 contacts the bottom surface of the recess 83 on the first surface 81. At this time, the rib 43 is positioned within the recess 83, and the step 83a is located on the outer circumference of the rib 43. The rib 43 faces the step 83a in a direction parallel to the first surface 81. The rib 43 may be in contact with the step 83a, or a gap may be formed between it and the step 83a. The contact of the rib 43 with the step 83a restricts the relative movement of the frame 2 with respect to the tray 8 in a direction parallel to the first surface 81. Specifically, movement of the frame 2 in any direction, front, back, left, or right, is blocked by the step 83a. This determines the position of the frame 2 in a direction parallel to the first surface 81. As a result, communication between each through hole 25 and the corresponding cell 85 is ensured.

[0066] Figure 12 shows the hardware configuration of the control device 6. The support device 1 is controlled by the control device 6. The control device 6 accepts setting inputs from the user. The control device 6 controls the display 3 according to the input settings. For example, the wiring of the display 3 is connected to the control device 6. The display 3 operates based on commands from the control device 6. An input device 64 and a display 65 are connected to the control device 6. The control device 6 accepts inputs from the user via the input device 64. The control device 6 displays various information on the display 65.

[0067] The display unit 3 and the control device 6 are connected via a cable. The display unit 3 is provided with a connector. The connection part of the connector on the display unit 3 is located in a position that is exposed to the outside in the support device 1. One end of the cable is connected to the connector on the display unit 3. The control device 6 is provided with a connector. The connection part of the connector on the control device 6 is located in a position that is exposed to the outside. The other end of the cable is connected to the connector on the control device 6. The control device 6 supplies power and signals to the display unit 3 via the cable. The control device 6 controls the display unit 3 via the cable. As the cable, for example, a USB cable, specifically a USB Type-C standard USB cable, is used.

[0068] The cable may be fixed in place while connected to the display unit 3. In this case, one end of the cable (the end on the display unit 3 side) may be housed in the internal space of the support device 1.

[0069] The control device 6 includes a main body of the control device 6 and a display control board for controlling the display unit 3, and the display control board may be provided separately from the main body of the control device 6. The display unit 3 and the main body of the control device 6 are connected via the display control board. The display unit 3 and the display control board are connected via a cable. The display control board and the main body of the control device 6 are connected via a cable. In this case, the display control board may be configured to be retrofitted to the drug packaging device 100 together with the support device 1. The display control board may be provided separately from the support device 1, or it may be housed in the internal space of the support device 1.

[0070] Furthermore, the control device 6 may be the control device 93 of the drug packaging device 100. The input device 64 may be the input device 95 of the drug packaging device 100. The display 65 may be the display 96 of the drug packaging device 100.

[0071] The control device 6 includes a processor 61, a memory 62, and a storage 63.

[0072] The processor 61 performs various arithmetic operations. For example, the processor 61 is formed by a processor such as a CPU (Central Processing Unit). The processor 61 may also be formed by an MCU (Micro Controller Unit), MPU (Micro Processor Unit), FPGA (Field Programmable Gate Array), PLC (Programmable Logic Controller), system LSI, etc.

[0073] Memory 62 temporarily stores data, etc. For example, memory 62 is made of volatile memory.

[0074] Storage 63 stores programs and various data executed by the processor 61. For example, storage 63 stores control programs.

[0075] The control device 6 may display a GUI on the display 65 for the user to input settings. For example, the settings may include the number of days to take the medication, the timing of administration each day, and the type and number of medications to be administered at each time.

[0076] The control device 6 accepts settings entered to the GUI via the input device 64. For example, settings such as the number of days of administration being 5 days, the timing of administration being morning, noon, and night, and the types and quantities of medication being 1 of the first medication, 1 of the second medication, and 2 of the third medication in the morning, 1 of the first medication and 1 of the second medication in the noon, and 1 of the first medication and 2 of the third medication in the evening are entered via the input device 64. The input device 64 accepts the entered settings.

[0077] The control device 6 controls the display unit 3 according to the input settings. For example, the control device 6 causes the display unit 3 corresponding to the cell 85 into which the drug is to be administered to display a specific message. The specific message is, for example, the illumination of the light emitter 3. That is, the control device 6 illuminates the display unit 3 corresponding to the cell 85 into which the drug is to be administered.

[0078] The control device 6 may change a specific display on the indicator 3 depending on the type and / or quantity of drug to be administered. For example, the control device 6 may set the displays on the indicator 3 corresponding to cells 85 with the same type and quantity of drug to be administered to be the same, and set the displays on the indicator 3 corresponding to cells 85 with different types or quantities of drug to be administered to be different. The user can identify cells 85 with the same combination of drug type and quantity to be administered from the display on the indicator 3. A specific display change is, for example, a change in the illumination color of the light emitter 3. For example, the control device 6 may set the illumination colors of the light emitter 3 corresponding to cells 85 with the same type and quantity of drug to be administered to be the same, and set the illumination colors of the light emitter 3 corresponding to cells 85 with different types or quantities of drug to be administered to be different. Specifically, the control device 6 lights up the light emitter 3 corresponding to the cell 85 with the first combination of type and quantity of drug to be introduced in the first color, the light emitter 3 corresponding to the cell 85 with the second combination of type and quantity of drug to be introduced in the second color, and the light emitter 3 corresponding to the cell 85 with the third combination of type and quantity of drug to be introduced in the third color.

[0079] Furthermore, the control device 6 may display the combination of the lighting color and the corresponding type and quantity of the drug on the display 65.

[0080] In this way, the control device 6 identifies the corresponding cell 85 based on the display on the indicator 3.

[0081] As described above, the support device 1, by being retrofitted to the tray 8 of the drug packaging device 100, enables the identification of multiple cells 85. Specifically, by installing the support device 1 on the tray 8, the display unit 3 can be placed at a position corresponding to each of the multiple cells 85. By connecting the display unit 3 and the control device 6 via a cable, display by the display unit 3 becomes possible. The display on the display unit 3 makes it possible to identify the target cell 85. Even if the drug packaging device 100 does not originally have the function to identify multiple cells 85, it is possible to easily achieve the identification of multiple cells 85 without modifying the drug packaging device 100.

[0082] By using a light-emitting device as the display unit 3 of the support device 1, the configuration of the display unit 3 can be simplified compared to when the display unit 3 is configured with a liquid crystal display or the like. Specifically, it is possible to distinguish between cells 85 in which the light-emitting device 3 is lit and cells 85 in which the light-emitting device 3 is off. Furthermore, by making the light-emitting device 3 blink, it is possible to distinguish between cells 85 in which the light-emitting device 3 is blinking and cells 85 in which the light-emitting device 3 is off or lit. Moreover, even among cells 85 in which the light-emitting device 3 is blinking, it is possible to distinguish between them based on the blinking pattern, such as the blinking speed.

[0083] Since the color of each light emitter 3 can be changed independently, the variations for identifying cell 85 can be increased. In other words, not only can the lights on and off of the light emitters 3 be used, but the color of the light emitted by the light emitters 3 can also be used to increase the types of cell 85 that can be identified.

[0084] Since the frame 2 has multiple through-holes 25 separated to communicate with each of the multiple cells 85, the drug can be properly dispensed into the cells 85 via the through-holes 25 even when the frame 2 is placed on the tray 8. Specifically, since the frame 2 is placed on the tray 8, the input port 85a may be difficult to see. Because the frame 2 has through-holes 25 that communicate with the cells 85, the drug is properly dispensed into the cells 85 corresponding to the through-holes 25 by dispensing the drug into the through-holes 25.

[0085] Of the multiple through-holes 25, the second opening 25b on the side of the input port 85a is positioned to fit within the input port 85a. Therefore, the chemical introduced through the through-hole 25 enters the cell 85 smoothly without getting caught on the first surface 81 of the tray 8 at the boundary between the through-hole 25 and the cell 85.

[0086] The support device 1 includes ribs 43 that position the frame 2 by contacting the corresponding portion of the tray 8. This determines the position of the frame 2 relative to the tray 8, so that the display unit 3 is properly positioned relative to the corresponding cell 85. Furthermore, the through-holes 25 are also properly positioned relative to the corresponding cell 85.

[0087] Since frame 2 has an extension plate 27 that extends to cover the handle 86 of tray 8, the user cannot access the handle 86 when the support device 1 is installed on tray 8. This prevents tray 8 from being removed from the drug packaging device 100 while the support device 1 is installed on tray 8.

[0088] <Variations> Next, a modified version of support device 1 will be described. Regarding the modified support device, the same configuration as support device 1 described above will be omitted from the explanation, and the differences will be the focus of the description. The same applies to the drug packaging device. The configuration of the support device will be changed depending on the drug packaging device to which it is applied.

[0089] Figure 13 is a perspective view of the drug packaging device 200 according to Modification 1. With respect to the configuration related to the support device 201, the drug packaging device 200 differs from the drug packaging device 100 in the configuration of the tray 208.

[0090] The tray 208 is detachably attached to the drug packaging device 200. For example, the tray 208 is detachably attached to the table 297 of the housing 290. The table 297, like the table 97, is slidable substantially horizontally on the upper surface of the housing 290.

[0091] Tray 208 has multiple cells 85. These cells 85 are arranged two-dimensionally. For example, the cells 85 are arranged in a matrix. In this example, the cells 85 are arranged in a 6x8 matrix.

[0092] The first surface 281 of the tray 208 may have a recess 283 that is more recessed than the rest of the first surface 281. That is, the first surface 281 includes the bottom surface of the recess 283 and an outer surface positioned around the periphery of the recess 283 and higher than the bottom surface of the recess 283. A step 283a is formed at the boundary between the recess 283 and the rest of the first surface 281. That is, the periphery of the recess 283 is demarcated by the step 283a. For example, the step 283a is positioned to form the four sides of a rectangle surrounding the periphery of the recess 283.

[0093] A rib 283b is positioned on the first surface 281. The rib 283b protrudes from the first surface 281. The rib 283b is formed in an annular shape so as to surround the entirety of a plurality of cells 85. The rib 283b includes portions that extend in the row direction and portions that extend in the column direction of the plurality of cells 85. The portions that extend in the row direction include portions that extend along the plurality of cells 85 in the first row and portions that extend along the plurality of cells 85 in the sixth row. The portions that extend in the column direction include portions that extend along the plurality of cells 85 in the first column and portions that extend along the plurality of cells 85 in the eighth column. The rib 283b may include portions other than those described above.

[0094] Figure 14 is a perspective view of the support device 201 according to modified example 1. The support device 201 comprises a frame 202 placed on a tray 208 and a plurality of displays 3 provided on the frame 202 and positioned corresponding to each of the plurality of cells 85.

[0095] Frame 202 has a first surface 21 that faces outward when frame 2 is placed on tray 8. Frame 202 has multiple through holes 25 that communicate with each of the multiple cells 85. The arrangement of the multiple indicators 3 corresponds to the arrangement of the multiple cells 85. For example, the multiple through holes 25 are arranged in a 6x8 matrix.

[0096] Figure 15 is a perspective view of the support device 201 from a different angle than that shown in Figure 14. The frame 202 may have a frame body 20 and a cover 204. The frame 202 has a second surface 222 that contacts the tray 208 when the frame 202 is placed on the tray 208.

[0097] The cover 204 may have a bottom wall 41 extending substantially parallel to the first surface 21, and side walls 42 connected to the bottom wall 41 and surrounding the first digit 23 and the second digit 24 from the outer periphery. Multiple first digits 23 and multiple second digits 24 protrude downward from the bottom wall 41.

[0098] The cover 204 may include ribs 243 projecting from the bottom wall 41 toward the opposite side of the first surface 21, i.e., downward. For example, the ribs 243 include a plurality of first ribs 243a extending along the second stile 24 and a plurality of second ribs 243b extending along the first stile 23. The plurality of first ribs 243a are positioned on both the outward sides in the row direction relative to the entire plurality of through holes 25. That is, one first rib 243a is positioned to the left of the plurality of through holes 25 in the first row, and another first rib 243a is positioned to the right of the plurality of through holes 25 in the eighth row. The plurality of second ribs 243b are positioned on one outward side in the row direction relative to the entire plurality of through holes 25. More specifically, the plurality of second ribs 243b are positioned behind the plurality of through holes 25 in the first row. The plurality of second ribs 243b are aligned linearly in the row direction. Each second rib 243b is positioned in the same location as the corresponding second digit 24 in the row direction.

[0099] Figure 16 is an enlarged cross-sectional view of the support device 201 and tray 208 in a section parallel to the row direction. Figure 17 is an enlarged cross-sectional view of the support device 201 and tray 208 in a section parallel to the column direction. Figure 16 is an enlarged view of the area around the through hole 25 and cell 85 of the first column. Figure 17 is an enlarged view of the area around the through hole 25 and cell 85 of the sixth row. The lower end surface of the rib 243 and the lower end surfaces of the first and second girders 23 and 24 are substantially flush. The lower end surfaces of the first girder 23, the second girder 24 and the rib 243 form a second surface 222. When the frame 202 is placed on the tray 208, the lower end surfaces of the first girder 23, the second girder 24 and the rib 243 contact the tray 208, specifically the first surface 281.

[0100] When the support device 201 is placed on the tray 208, the multiple first digits 23, multiple second digits 24, and ribs 243 fit into the recesses 283 and are surrounded by the steps 283a. The ribs 243 face the steps 283a in a direction parallel to the first surface 281. For example, as shown in Figure 16, the steps 283a are located to the left of the left first rib 243a. The left first rib 243a and the steps 283a face each other with a small gap between them. Similarly, the right first rib 243a and the second rib 243b also face the steps 283a. The ribs 243 may be in contact with the steps 283a, or a gap may be formed between them and the steps 283a.

[0101] Furthermore, when the support device 201 is placed on the tray 208, at least a portion of the side periphery wall 42 of the cover 204 faces the rib 283b of the tray 208 in a direction parallel to the first surface 281. For example, as shown in Figure 17, the portion of the side periphery wall 42 extending along the sixth row of through holes 25 faces the rib 283b with a small gap between them. The side periphery wall 42 may be in contact with the rib 283b, or a gap may be formed between it and the rib 283b.

[0102] The side walls 42 and ribs 243 of the cover 204 position the frame 202 by contacting the corresponding portion of the tray 208. In other words, the side walls 42 and ribs 243 are positioning members that position the frame 202 on the surface of the tray 208 on which the frame 202 is placed, i.e., in a direction parallel to the first surface 281. Specifically, the side wall 42 contacts the rib 283b, restricting the relative movement of the frame 202 with respect to the tray 208 in a direction parallel to the first surface 281. The rib 243 also contacts the step 283a, restricting the relative movement of the frame 202 with respect to the tray 208 in a direction parallel to the first surface 281. For example, movement of the frame 202 in any direction—forward, backward, left, or right—is blocked by the step 283a or rib 283b. This determines the position of the frame 202 in a direction parallel to the first surface 281. As a result, communication between each through-hole 25 and the corresponding cell 85 is ensured. Furthermore, the display unit 3 is also appropriately positioned relative to the corresponding cell 85.

[0103] Similar to support device 1, this support device 201 can be retrofitted to the tray 208 of the drug packaging device 200, enabling the identification of multiple cells 85. Specifically, by installing support device 201 on the tray 208, the display unit 3 can be positioned at a location corresponding to each of the multiple cells 85. The display on the display unit 3 makes it possible to identify the target cell 85.

[0104] Figure 18 is a perspective view of the drug packaging device 300 according to Modification 2. The drug packaging device 300 differs from the drug packaging device 100 in that the tray 308 cannot be removed from the housing 390, and the housing 390 does not have a sliding table.

[0105] The tray 308 is positioned on the top surface of the housing 390. Unlike the drug packaging device 100, the drug packaging device 300 does not have a sliding table. The tray 308 is fixed to the housing 390.

[0106] The first surface 381 of the tray 308 may have a recess 383 that is recessed more than the rest of the first surface 381. That is, the first surface 381 includes the bottom surface of the recess 383 and an outer peripheral surface positioned on the outer periphery of the recess 383 and higher than the bottom surface of the recess 383. A step 383a is formed at the boundary between the recess 383 and the rest of the first surface 381. That is, the outer periphery of the recess 383 is demarcated by the step 383a.

[0107] The tray 308 has multiple cells 85. The multiple cells 85 are located on the bottom surface of the recess 383. The multiple cells 85 are arranged two-dimensionally. For example, the multiple cells 85 are arranged in a matrix. In this example, the multiple cells 85 are arranged in a 6x8 matrix. However, the 8th column contains three cells 85 from the 1st to the 3rd row, and does not contain any cells 85 from the 4th to the 6th row.

[0108] For example, step 383a surrounds the entire outer perimeter of multiple cells 85. Specifically, step 383a includes portions that extend in the row direction and portions that extend in the column direction of the multiple cells 85. The portion that extends in the row direction includes portions that extend along the multiple cells 85 of the first row, portions that extend along the multiple cells 85 of the sixth row, and portions that extend along the cells 85 of the third row of the eighth column. The portion that extends in the column direction includes portions that extend along the multiple cells 85 of the first column, portions that extend along the multiple cells 85 of the fourth to sixth rows of the seventh column, and portions that extend along the multiple cells 85 of the first to third rows of the eighth column.

[0109] Figure 19 is a perspective view of the support device 301 according to the second modified example. The support device 301 comprises a frame 302 placed on a tray 308 and a plurality of displays 3 provided on the frame 302 and positioned at locations corresponding to each of the plurality of cells 85.

[0110] Frame 302 has multiple through-holes 325 separated to communicate with each of the multiple cells 85. In this example, there are more through-holes 325 than cells 85. Specifically, the multiple through-holes 325 are arranged in a 6x8 matrix. The eighth column of tray 308 contains three cells 85 from the first to the third row, while the eighth column of frame 302 contains six through-holes 325 from the first to the sixth row. In other words, the three through-holes 325 from the fourth to the sixth row of the eighth column do not communicate with the cells 85 of tray 308.

[0111] An array of multiple indicators 3 corresponds to an array of multiple cells 85. In this example, there are more indicators 3 than multiple cells 85. Specifically, the indicators 3 are arranged in a 6x8 matrix. The 8th column of tray 308 contains three cells 85 from the 1st to the 3rd row, while the 8th column of frame 302 contains six indicators 3 from the 1st to the 6th row.

[0112] Furthermore, in the eighth column of frame 302, three through holes 325 are included from the first to the third row, but through holes 325 may not be included from the fourth to the sixth row. In the eighth column of frame 302, three indicators 3 are included from the first to the third row, but indicators 3 may not be included from the fourth to the sixth row.

[0113] Figure 20 is a perspective view of the support device 301 from a different angle than that shown in Figure 19. The frame 302 has a frame body 320 and a spacer 305 positioned between the frame body 320 and the tray 308 and attached to the frame body 320. The frame 302 may have a cover 4. The spacer 305 is attached to the frame body 320 from the side opposite the first surface 21. For example, the spacer 305 is attached to the first digit 23 and the second digit 24.

[0114] The through-hole 325 penetrates the frame body 320 and the spacer 305. Part of the through-hole 325 is formed in the frame body 320, and the remaining part of the through-hole 325 is formed in the spacer 305. The first opening 325a of the multiple through-holes 325 opens to the first surface 21. The second opening 325b of the multiple through-holes 325, which is the opening on the side of the input port 85a, is located in the spacer 305.

[0115] The spacer 305 has an outer circumference shape that fits into the recess 383, i.e., a planar shape. The spacer 305 is positioned in the parts of the multiple through holes 325 that communicate with multiple cells 85, and is not positioned in the parts of the multiple through holes 325 that do not communicate with multiple cells 85.

[0116] In the spacer 305, the portion corresponding to the multiple through holes 325 in the first row is provided with multiple protrusions 351 that project outward in the row direction.

[0117] Figure 21 is an enlarged cross-sectional view of the support device 301 and tray 308. Figure 21 is an enlarged view of the area around the eighth row through hole 325 and cell 85. The frame 302 is placed on the tray 308 via spacers 305. The spacers 305 are in contact with the first surface 381 of the tray 308.

[0118] The lower end surface of the spacer 305 forms a second surface 322. When the frame 302 is placed on the tray 308, the lower end surface of the spacer 305 contacts the tray 308, specifically the first surface 381.

[0119] When the support device 301 is placed on the tray 308, the spacer 305 fits into the recess 383. The spacer 305 is surrounded by the step 383a. The spacer 305 faces the step 383a in a direction parallel to the first surface 381. For example, as shown in Figure 21, the spacer 305 and the step 383a face each other with a small gap between them. The spacer 305 may be in contact with the step 383a, or a gap may be formed between it and the step 383a. In the portion of the spacer 305 corresponding to the multiple through holes 325 in the first row, the multiple protrusions 351 face each other with a small gap between them and the step 383a.

[0120] The spacer 305 positions the frame 302 by contacting the corresponding portion of the tray 308. In other words, the spacer 305 is a positioning member that positions the frame 302 on the surface of the tray 308 on which the frame 302 is placed, i.e., in a direction parallel to the first surface 381. More specifically, a step 383a is located on the outer circumference of the spacer 305. By the spacer 305 contacting the step 383a, the relative movement of the frame 302 with respect to the tray 308 in the direction parallel to the first surface 381 is restricted. Specifically, movement of the frame 302 in any direction—forward, backward, left, or right—is blocked by the step 383a. This determines the position of the frame 302 in the direction parallel to the first surface 381. As a result, communication between each through-hole 325 and the corresponding cell 85 is ensured. Furthermore, the display unit 3 is also appropriately positioned relative to the corresponding cell 85.

[0121] Similar to support device 1, this support device 301 can be retrofitted to the tray 308 of the drug packaging device 300, enabling the identification of multiple cells 85. Specifically, by installing the support device 301 on the tray 308, the display unit 3 can be positioned at a location corresponding to each of the multiple cells 85. The display on the display unit 3 makes it possible to identify the target cell 85.

[0122] Other embodiments As described above, the embodiments described herein have been presented as examples of the technology disclosed in this application. However, the technology in this disclosure is not limited thereto and can be applied to embodiments that have been modified, replaced, added, or omitted as appropriate. Furthermore, it is possible to combine the components described in the embodiments above to create new embodiments. In addition, the components described in the attached drawings and detailed description may include not only components essential for solving the problem, but also components that are not essential for solving the problem, in order to illustrate the technology. Therefore, the mere presence of such non-essential components in the attached drawings and detailed description should not be immediately assumed to mean that those non-essential components are essential.

[0123] For example, the configuration of the drug packaging device and support device is merely an example. The configuration of the support device can be changed according to the corresponding drug packaging device. Even with the same drug packaging device, the configuration of the support device can be arbitrarily changed. For example, trays 8,208 may be permanently attached to table 97.

[0124] The external shape of frames 2, 202, and 302 is not limited to a rectangle. Frame 2, 202 does not have to have an extension plate 27. Frames 2, 202, and 302 do not have to have covers 4, 204. Frame 2, 202 may have a spacer 305, like frame 302.

[0125] For example, the first digit 23 and the second digit 24 extend from the top plate 26 to the side opposite the first surface 21, but are not limited to this. The thickness of the first digit 23 and the second digit 24 is the same as that of the top plate 26, and the first digit 23, the second digit 24, and the top plate 26 may be formed from flat plates of uniform thickness.

[0126] Frames 2,202,302 may be formed from flexible sheets.

[0127] Frames 2,202,302 can adopt any configuration as long as they have a display unit 3. A single through-hole 25,325 may communicate with multiple cells 85. For example, a single through-hole 25,325 may communicate with four cells 85 arranged in a 2x2 matrix. A single through-hole 25,325 may communicate with multiple cells 85 arranged in the row or column direction. Frames 2,202,302 do not have to be formed in a grid pattern. For example, frame 2,202,302 may have only the digits on which the display unit 3 is placed, i.e., only one of the first digit 23 and the second digit 24.

[0128] The number of display units 3 does not have to be the same as the number of cells 85. The number of display units 3 may be more or less than the number of cells 85. From the viewpoint of effectively utilizing all cells 85 of the pharmaceutical packaging device, it is preferable that the number of display units 3 is equal to or greater than the number of cells 85.

[0129] The arrangement of the indicator 3 is not limited to the arrangement described above. The indicator 3 may be placed in the second digit 24 on the right side of each through-hole 25. The orientation in which the indicator 3 is placed relative to the corresponding through-hole 25 does not have to be the same for all indicators 3. The indicator 3 may be placed in the first digit 23. The indicator 3 may be placed on the first surface 21 instead of the inner circumferential surface of the through-hole 25. In that case, the indicator 3 may be placed adjacent to the first opening 25a on the first surface 21.

[0130] The display unit 3 is not limited to a light-emitting device. The display unit 3 may be a liquid crystal display or an organic EL display. If the display unit 3 is a light-emitting device, the light-emitting device does not need to be able to change the color of the light. Even if the display unit 3 cannot change the color of the light, the variations for identifying cell 85 can be increased by changing the mode of illumination, such as being off, on, and blinking.

[0131] The method by which the display unit 3 distinguishes between multiple cells 85 can be arbitrarily set according to the purpose of use of the support device.

[0132] The positioning members for positioning frames 2,202,302 are not limited to the side walls 42, ribs 43, ribs 243, and spacers 305. The positioning members may also be the frame body 20, the first stile 23, or the second stile 24, etc.

[0133] The functions realized by the components described herein may be implemented in circuits or processing circuits, including general-purpose processors, application-specific processors, integrated circuits, ASICs (Application Specific Integrated Circuits), CPUs (Central Processing Units), conventional circuits, and / or combinations thereof, programmed to realize the functions described herein. A processor includes transistors and other circuits and is considered a circuit or processing circuit. A processor may be a programmable processor that executes a program stored in memory.

[0134] In this specification, circuits, units, and means are hardware programmed to perform or execute the functions described herein. Such hardware may be any hardware disclosed herein, or any hardware known to be programmed to perform or execute the functions described herein.

[0135] If the hardware is a processor that is considered to be a type of circuit, then the circuit, means, or unit is a combination of hardware and software used to constitute the hardware and / or processor.

[0136] [Pattern] The above embodiment is a specific example of the following embodiment.

[0137] (Aspect 1) The support device 1,201,301 is a support device that is retrofitted to a tray 8,208,308, which is included in a drug packaging device 100,200,300 for packaging drugs, and has a plurality of cells 85 into which drugs are loaded from an input port 85a. The support device 1,201,301 comprises a frame 2,202,302 placed on the tray 8,208,308, and a plurality of indicators 3 arranged on the frame 2,202,302 at positions corresponding to each of the plurality of cells 85.

[0138] With this configuration, by placing the frame 2 on the tray 8, multiple display units 3 can be positioned at locations corresponding to each of the multiple cells 85. By using the display units 3, the target cell 85 can be easily distinguished from other cells 85. For example, the user can be easily informed of the cell 85 into which the drug should be placed by the display on the display unit 3. As a result, support for the distribution process can be achieved without making any special changes to the drug packaging device 100.

[0139] (Aspect 2) In the support device 1,201,301 described in Aspect 1, the plurality of display units 3 are a plurality of light emitters 3 that emit light.

[0140] This configuration allows for a simple setup of the display unit 3.

[0141] (Aspect 3) In the support device 1,201,301 described in Aspect 1 or Aspect 2, the plurality of light emitters 3 are configured to allow the color of light to be changed independently of each other.

[0142] With this configuration, the target cell 85 can be easily distinguished from other cells 85 by the color of its light. In other words, the variations in the display of the indicator 3 can be increased by the color of the light, in addition to the on / off state and lighting pattern of the light. This makes it possible to distinguish multiple cells 85 into various types.

[0143] (Aspect 4) In the support device 1,201,301 described in any one of aspects 1 to 3, the frame 2,202,302 has a plurality of through holes 25,325 separated to communicate with each of the plurality of cells 85.

[0144] In this configuration, when the drug is introduced into the through-holes 25 and 325, it is introduced into the corresponding cell 85 through the through-holes 25 and 325. Even in a configuration where frames 2,202 and 302 are placed on trays 8,208 and 308, the drug can be properly introduced into the target cell 85.

[0145] (Aspect 5) In the support device 1,201,301 described in any one of aspects 1 to 4, the second openings 25b,325b of the plurality of through holes 25,325 on the side of the input port 85a are arranged to fit inside the input port 85a.

[0146] This configuration prevents the drug from getting caught on the surface of trays 8, 208, and 308 at the boundary between the through-holes 25 and 325 and the cell 85. As a result, the drug introduced into the through-holes 25 and 325 flows smoothly from the through-holes 25 and 325 into the cell 85.

[0147] (Aspect 6) The support device 1,201,301 described in any one of aspects 1 to 5 further comprises a positioning member for positioning the frames 2,202,302 in a direction parallel to the first surface 81,281,381 on which the frames 2,202,302 are placed among the trays 8,208,308, wherein the positioning member positions the frames 2,202,302 by contacting the corresponding portion of the trays 8,208,308.

[0148] With this configuration, frames 2,202,302 are properly positioned relative to trays 8,208,308. As a result, display unit 3 is properly positioned relative to the corresponding cell 85.

[0149] (Aspect 7) In the support device 1,201 described in any one of aspects 1 to 6, the tray 8,208 has a handle 86 for being grasped by a user and is detachably attached to the drug packaging device 100,200, and the frame 2,202 has an expansion plate 27 that expands to cover the handle 86.

[0150] With this configuration, when the support device 1,201 is placed on the tray 8,208, the handle 86 of the tray 8,208 is covered by the extension plate 27 of the frame 2,202. The user is unable to access the handle 86 when the support device 1,201 is placed on the tray 8,208. As a result, it is prevented that the tray 8,208 will not be removed from the drug packaging device 100,200 while the support device 1,201 is still placed on it.

[0151] (Aspect 8) In the support device 301 described in any one of aspects 1 to 7, the frame 302 has a frame body 320 and a spacer 305 which is disposed between the frame body 320 and the tray 308 and attached to the frame body 320, and is placed on the tray 308 via the spacer 305.

[0152] In this configuration, the frame 302 is placed on the tray 308 via the spacer 305. This allows the distance between the frame body 320 and the tray 308 to be adjusted by the spacer 305.

[0153] (Aspect 9) In the support device 301 described in any one of aspects 1 to 8, the through hole 325 penetrates the frame body 320 and the spacer 305.

[0154] With this configuration, the through-hole 325 penetrates the frame body 320 and the spacer 305, making it easier for the through-hole 325 to communicate properly with the cell 85.

[0155] (Aspect 10) In the support device 1,201,301 described in any one of aspects 1 to 9, the plurality of display units 3 are connected to the control device 93 of the drug packaging device 100,200,300 and controlled by the control device 93.

[0156] This configuration simplifies the setup compared to a case where a separate control device is required to control multiple displays 3. [Explanation of symbols]

[0157] 100, 200, 300 Pharmaceutical packaging equipment 1,201,301 Support equipment 2,202,302 frames 25,325 through holes 25b, 325b 2nd opening 20,320 Frame body 305 Spacer (positioning member) 42 Side periphery wall (positioning member) 43,243 Ribs (positioning members) 8,208,308 trays 85 cells 85a Inlet 86 Handle

Claims

1. An auxiliary device that is retrofitted to a tray having multiple cells into which pharmaceuticals are introduced from an input opening, which is included in a pharmaceutical packaging device for packaging pharmaceuticals, A frame placed on the tray, A support device comprising a plurality of displays arranged in the frame at positions corresponding to each of the plurality of cells.

2. In the support device according to claim 1, The aforementioned multiple display devices are support devices that consist of multiple light-emitting devices.

3. In the support device according to claim 2, The aforementioned plurality of light emitters are configured to allow the color of each light to be changed independently.

4. In the support device according to claim 1, The frame is a support device having a plurality of through holes separated to communicate with each of the plurality of cells.

5. In the support device according to claim 4, The opening of the plurality of through holes on the side of the input port is a support device positioned to fit within the input port.

6. In the support device according to claim 1, The tray further comprises a positioning member for positioning the frame in a direction parallel to the surface on which the frame is placed, The positioning member is an assisting device that positions the frame by contacting a corresponding portion of the tray.

7. In the support device according to claim 1, The tray has a handle that can be grasped by the user and is detachably attached to the drug packaging device. The frame is a support device having an expansion plate that extends to cover the handle.

8. In the support device according to claim 1, The frame comprises a frame body and a spacer positioned between the frame body and the tray and attached to the frame body, and is a support device placed on the tray via the spacer.

9. In the support device according to claim 8, The through-hole is a support device that penetrates the frame body and the spacer.

10. In the support device according to claim 1, The plurality of displays are connected to the control device of the drug packaging apparatus and are support devices controlled by the control device.

Citation Information

Patent Citations

  • Medicine packaging apparatus

    WO2008035701A1